LY011 / China Biotech Services 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LY011 / China Biotech Services
NCT04977193: A Study to Evaluate the Safety and Efficacy of ly011 Cell Injection in the Treatment of Advanced Gastric Adenocarcinoma

Recruiting
1
18
RoW
LY011
Shanghai Longyao Biotechnology Inc., Ltd., The Affiliated Hospital of Xuzhou Medical University
Advanced Gastric Adenocarcinoma
05/23
11/24
NCT04966143: Clinical Study of LY011 in the Treatment of Advanced Pancreatic Cancer

Recruiting
1
30
RoW
LY011
Shanghai Longyao Biotechnology Inc., Ltd.
Pancreatic Cancer
08/23
08/24

Download Options